Article

Virtual Screening Based Prediction of Potential Drugs for COVID-19

2020-03-09

Abstract excerpt

SARS-CoV-2 is the betacoronavirus responsible for the COVID-19 pandemic. It was listed as a potential global health threat by WHO due to high mortality, high basic reproduction number and lack of clinically approved drugs and vaccines for COVID-19. The genomic sequence of the virus responsible for COVID-19, as well as the experimentally determined three dimensional structure of the Main protease (Mpro) are availab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c09e3c95-d513-5146-9b36-210328a43275
DOI: 10.20944/preprints202002.0418.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Virtual Screening Based Prediction of Potential Drugs for COVID-19DOI 10.20944/preprints202002.0418.v2Read

In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2Semantic proximity Read

Computational studies by molecular docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19Semantic proximity Read

Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)Semantic proximity Read

Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity Read

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity Read

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease InhibitorsSemantic proximity Read

Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity Read

Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approachSemantic proximity Read

An in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main proteaseSemantic proximity Read

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studiesSemantic proximity Read

In-Silico Lead Druggable Compounds Identification against SARS COVID-19 Main Protease Target from In-House, Chembridge and Zinc Databases by Structure-Based Virtual Screening, Molecular Docking and Molecular Dynamics SimulationsSemantic proximity Read

Identification of promising high-affinity inhibitors of SARS-CoV-2 main protease from African Natural Products Databases by Virtual ScreeningSemantic proximity Read